Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) investigated the role of semaglutide in reducing cardiovascular outcomes in patients with obesity and pre-existing cardiovascular disease, but no diabetes was investigated
Safety Data Sheet available for laboratory handling and storage information
To sustain the benefits of weight loss and prevent weight regain, ongoing treatment with semaglutide is often necessary
The biological reason is straightforward sublingual and buccal absorption of large peptide molecules like semaglutide is variable and generally lower than injection bioavailability
Stay Healthy
US$ 27.67
US$ 24.26
US$ 20.88
US$ 28.29
.png)
US$ 22.38
